New injection HRS-2162 tested for safety in healthy adults
NCT ID NCT07195604
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This early-stage study is testing a single injection of HRS-2162 in 64 healthy adults aged 18 to 45. The main goal is to check if the drug is safe and to see how the body absorbs and processes it. This research is a first step toward developing a treatment that could reverse muscle paralysis caused by other medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSAL OF NEUROMUSCULAR BLOCKADE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
Contact
Conditions
Explore the condition pages connected to this study.